Avoro Capital Advisors LLC Kymera Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

$6.18 Billion
Q1 2025

A detailed history of Avoro Capital Advisors LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 6,460,000 shares of KYMR stock, worth $290 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares

6,460,000

Previous 5,150,000 25.44%

Holding current value

$290 Million

Previous $207 Million 14.66%

% of portfolio

2.86%

Previous 3.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$27.37 - $44.36 $35.9 Million - $58.1 Million	1,310,000 Added 25.44%	6,460,000 $177 Million
Q4 2024 Feb 14, 2025	BUY	$39.06 - $51.84 $25.4 Million - $33.7 Million	650,000 Added 14.44%	5,150,000 $207 Million
Q3 2024 Nov 14, 2024	BUY	$30.16 - $52.4 $18.4 Million - $32 Million	611,112 Added 15.71%	4,500,000 $213 Million
Q1 2024 May 15, 2024	BUY	$22.9 - $43.57 $2.61 Million - $4.96 Million	113,888 Added 3.02%	3,888,888 $156 Million
Q4 2023 Feb 14, 2024	SELL	$10.97 - $26.84 $877,600 - $2.15 Million	-80,000 Reduced 2.08%	3,775,000 $96.1 Million
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $124,200 - $193,750	5,000 Added 0.13%	3,855,000 $114 Million
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $32.9 Million - $52 Million	1,680,770 Added 77.48%	3,850,000 $96.1 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $19 Million - $31.2 Million	909,230 Added 72.16%	2,169,230 $47.2 Million
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $6.27 Million - $18.9 Million	443,500 Added 54.32%	1,260,000 $24.8 Million
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $9.41 Million - $17.2 Million	266,500 Added 48.45%	816,500 $34.6 Million
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $4.7 Million - $6.18 Million	94,250 Added 20.68%	550,000 $34.9 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $21.8 Million - $30.4 Million	455,750 New	455,750 $26.8 Million
Q4 2020 Feb 16, 2021	SELL	$28.07 - $87.83 $1.39 Million - $4.34 Million	-49,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $1.29 Million - $1.64 Million	49,400 New	49,400 $1.6 Million

Others Institutions Holding KYMR

# of Institutions

180

Shares Held

67.4M

Call Options Held

223K

Put Options Held

241K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.46B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC Kymera Therapeutics, Inc. Transaction History